JCR Pharmaceuticals Co., Ltd. (OTCMKTS:JCRRF – Get Free Report) shares were up 0.3% during mid-day trading on Monday . The stock traded as high as $3.33 and last traded at $3.33. Approximately 150 shares changed hands during trading, a decline of 61% from the average session volume of 383 shares. The stock had previously closed at $3.32.
JCR Pharmaceuticals Price Performance
The stock has a 50-day simple moving average of $3.28 and a 200 day simple moving average of $3.77.
JCR Pharmaceuticals Company Profile
JCR Pharmaceuticals Co, Ltd. is a Japan-based biotechnology company specializing in the development, production and commercialization of plasma-derived products and regenerative medicine solutions. The company focuses on manufacturing high-purity plasma proteins, including human serum albumin, immunoglobulins and coagulation factors, to support a range of therapeutic applications in hematology, immunology and critical care settings.
In its plasma-derived business, JCR leverages state-of-the-art fractionation and purification processes to supply products such as intravenous immunoglobulin and albumin formulations.
Further Reading
- Five stocks we like better than JCR Pharmaceuticals
- Photronics Is Quietly Becoming a Key Winner From the AI Boom
- Looking Beyond NVIDIA? These 3 AI ETFs Are Beating the Market
- Palantir’s Kool-Aid Moment: The Math Behind Karp’s Forecast
- OpenAI’s Jalapeño Chip Could Change the AI Hardware Race
Receive News & Ratings for JCR Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for JCR Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
